Global Polymerase Chain Reaction Market Size study, by Type (Conventional PCR, Others), by Product (Consumables & Reagents, Instruments, software & services), by Application (Medical & Non-medical), and Regional Forecasts 2021-2027
- Category: Chemical & Material
- Published Date: Oct 2021
- Publisher: Bizwit Research
- Pages: 200
Global Polymerase Chain Reaction Market is valued approximately at USD 23.6 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 0.9% over the forecast period 2021-2027. Polymerase chain reaction is a method which is used to make various numerous copies of specific sample and its testing to find and deduct any kind of diseases. The polymerase chain reaction enables the investigators to obtain large quantities of DNA which are required for various experiments and procedures in molecular biology, The global Polymerase Chain Reaction market is being driven by rising incidence of chronic diseases, infectious diseases, and genetic disorders, as it is being used for sampling and testing purpose. Also, technological advancement in PCR is driving the growth of polymerase chain market. Furthermore, the increase in demand for rapid diagnostic tests and growing adoption of PCR technologies, will provide new opportunities for the global Polymerase Chain Reaction industry. For instance, according to the World Population Prospects report of 2019, one in every six people across world will be over 65 years of age by year 2050, which may increase the incidences of chronic diseases. Also, rise in prevalence of covid-19 cases is rise demand for use polymerase chain reaction of, as the spread of covid-19 disease has necessitated the use of Polymerase Chain Reaction for testing purpose as there has been rise in incidences of covid-19 cases from 4,92351 cases as of March 2021 which increases to about 8,00,000 cases in April 2021. As a result, increase in prevalence of infectious diseases and rising geriatric population the use of more polymerase chain reaction in the testing of different samples parts, which will serve as a catalyst for the Polymerase Chain Reaction industry in the future. However, High qPCR device costs and stringent regulatory policies , may impede market growth over the forecast period of 2021-2027.
Asia Pacific, North America, Europe, Latin America, and Rest of the World are the key region considered for the regional analysis of global polymerase chain reaction market. Favorable government initiatives, coupled with flexible regulatory guidelines makes North America the leading region across the world in terms of market share. Whereas Asia pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to improvements in healthcare infrastructure, an increase in patient awareness levels, and high unmet patient needs in the region.
Major market player included in this report are:
Abbott
Qiagen
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Cytiva (GE Healthcare)
bioMérieux SA
Hoffmann-La Roche Ltd.
Fluidigm Corporation
Stilla
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Polymerase Chain Reaction offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Conventional PCR
Others
By Product:
Consumables & Reagents
Instruments
software & services
By Application:
Medical
Non-medical
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Global Polymerase Chain Reaction Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Asia Pacific, North America, Europe, Latin America, and Rest of the World are the key region considered for the regional analysis of global polymerase chain reaction market. Favorable government initiatives, coupled with flexible regulatory guidelines makes North America the leading region across the world in terms of market share. Whereas Asia pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to improvements in healthcare infrastructure, an increase in patient awareness levels, and high unmet patient needs in the region.
Major market player included in this report are:
Abbott
Qiagen
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Cytiva (GE Healthcare)
bioMérieux SA
Hoffmann-La Roche Ltd.
Fluidigm Corporation
Stilla
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Polymerase Chain Reaction offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Conventional PCR
Others
By Product:
Consumables & Reagents
Instruments
software & services
By Application:
Medical
Non-medical
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Global Polymerase Chain Reaction Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Polymerase Chain Reaction Market , by Region, 2019-2027 (USD Billion)
1.2.2. Polymerase Chain Reaction Market , by Type, 2019-2027 (USD Billion)
1.2.3. Polymerase Chain Reaction Market , by Product , 2019-2027 (USD Billion)
1.2.4. Polymerase Chain Reaction Market , by Application, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Polymerase Chain Reaction Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Polymerase Chain Reaction Market Dynamics
3.1. Polymerase Chain Reaction Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rising incidence of chronic diseases, infectious diseases, and genetic disorders
3.1.1.2. Technological advancements in PCR
3.1.2. Market Restraint
3.1.2.1. High qPCR device costs
3.1.2.2. Stringent regulatory policies
3.1.3. Market Opportunities
3.1.3.1. Increasing demand for rapid diagnostic tests and growing adoption of PCR technologies
3.1.3.2. Increasing number of CROs and forensic & research laboratories
Chapter 4. Global Polymerase Chain Reaction Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Polymerase Chain Reaction Market , by Type
5.1. Market Snapshot
5.2. Global Polymerase Chain Reaction Market by Type, Performance - Potential Analysis
5.3. Global Polymerase Chain Reaction Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Polymerase Chain Reaction Market , Sub Segment Analysis
5.4.1. Conventional PCR
5.4.2. Others
Chapter 6. Global Polymerase Chain Reaction Market , by Product
a. Market Snapshot
6.1. Global Polymerase Chain Reaction Market by Product, Performance - Potential Analysis
6.2. Global Polymerase Chain Reaction Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
6.3. Polymerase Chain Reaction Market , Sub Segment Analysis
6.3.1. Consumables & Reagents
6.3.2. Instruments
6.3.3. Software & services
Chapter 7. Global Polymerase Chain Reaction Market , by Application
b. Market Snapshot
7.1. Global Polymerase Chain Reaction Market by Application, Performance - Potential Analysis
7.2. Global Polymerase Chain Reaction Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
7.3. Polymerase Chain Reaction Market , Sub Segment Analysis
7.3.1. Medical
7.3.2. Non-medical
Chapter 8. Global Polymerase Chain Reaction Market , Regional Analysis
8.1. Polymerase Chain Reaction Market , Regional Market Snapshot
8.2. North America Polymerase Chain Reaction Market
8.2.1. U.S. Polymerase Chain Reaction Market
8.2.1.1. Type breakdown estimates & forecasts, 2018-2027
8.2.1.2. Product breakdown estimates & forecasts, 2018-2027
8.2.1.3. Application breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Polymerase Chain Reaction Market
8.3. Europe Polymerase Chain Reaction Market Snapshot
8.3.1. U.K. Polymerase Chain Reaction Market
8.3.2. Germany Polymerase Chain Reaction Market
8.3.3. France Polymerase Chain Reaction Market
8.3.4. Spain Polymerase Chain Reaction Market
8.3.5. Italy Polymerase Chain Reaction Market
8.3.6. Rest of Europe Polymerase Chain Reaction Market
8.4. Asia-Pacific Polymerase Chain Reaction Market Snapshot
8.4.1. China Polymerase Chain Reaction Market
8.4.2. India Polymerase Chain Reaction Market
8.4.3. Japan Polymerase Chain Reaction Market
8.4.4. Australia Polymerase Chain Reaction Market
8.4.5. South Korea Polymerase Chain Reaction Market
8.4.6. Rest of Asia Pacific Polymerase Chain Reaction Market
8.5. Latin America Polymerase Chain Reaction Market Snapshot
8.5.1. Brazil Polymerase Chain Reaction Market
8.5.2. Mexico Polymerase Chain Reaction Market
8.6. Rest of The World Polymerase Chain Reaction Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abbott
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Qiagen
9.2.3. Bio-Rad Laboratories, Inc.
9.2.4. Agilent Technologies, Inc.
9.2.5. Thermo Fisher Scientific, Inc.
9.2.6. Cytiva (GE Healthcare)
9.2.7. bioMérieux SA
9.2.8. Hoffmann-La Roche Ltd.
9.2.9. Fluidigm Corporation
9.2.10. Stilla
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Polymerase Chain Reaction Market , by Region, 2019-2027 (USD Billion)
1.2.2. Polymerase Chain Reaction Market , by Type, 2019-2027 (USD Billion)
1.2.3. Polymerase Chain Reaction Market , by Product , 2019-2027 (USD Billion)
1.2.4. Polymerase Chain Reaction Market , by Application, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Polymerase Chain Reaction Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Polymerase Chain Reaction Market Dynamics
3.1. Polymerase Chain Reaction Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rising incidence of chronic diseases, infectious diseases, and genetic disorders
3.1.1.2. Technological advancements in PCR
3.1.2. Market Restraint
3.1.2.1. High qPCR device costs
3.1.2.2. Stringent regulatory policies
3.1.3. Market Opportunities
3.1.3.1. Increasing demand for rapid diagnostic tests and growing adoption of PCR technologies
3.1.3.2. Increasing number of CROs and forensic & research laboratories
Chapter 4. Global Polymerase Chain Reaction Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Polymerase Chain Reaction Market , by Type
5.1. Market Snapshot
5.2. Global Polymerase Chain Reaction Market by Type, Performance - Potential Analysis
5.3. Global Polymerase Chain Reaction Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Polymerase Chain Reaction Market , Sub Segment Analysis
5.4.1. Conventional PCR
5.4.2. Others
Chapter 6. Global Polymerase Chain Reaction Market , by Product
a. Market Snapshot
6.1. Global Polymerase Chain Reaction Market by Product, Performance - Potential Analysis
6.2. Global Polymerase Chain Reaction Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
6.3. Polymerase Chain Reaction Market , Sub Segment Analysis
6.3.1. Consumables & Reagents
6.3.2. Instruments
6.3.3. Software & services
Chapter 7. Global Polymerase Chain Reaction Market , by Application
b. Market Snapshot
7.1. Global Polymerase Chain Reaction Market by Application, Performance - Potential Analysis
7.2. Global Polymerase Chain Reaction Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
7.3. Polymerase Chain Reaction Market , Sub Segment Analysis
7.3.1. Medical
7.3.2. Non-medical
Chapter 8. Global Polymerase Chain Reaction Market , Regional Analysis
8.1. Polymerase Chain Reaction Market , Regional Market Snapshot
8.2. North America Polymerase Chain Reaction Market
8.2.1. U.S. Polymerase Chain Reaction Market
8.2.1.1. Type breakdown estimates & forecasts, 2018-2027
8.2.1.2. Product breakdown estimates & forecasts, 2018-2027
8.2.1.3. Application breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Polymerase Chain Reaction Market
8.3. Europe Polymerase Chain Reaction Market Snapshot
8.3.1. U.K. Polymerase Chain Reaction Market
8.3.2. Germany Polymerase Chain Reaction Market
8.3.3. France Polymerase Chain Reaction Market
8.3.4. Spain Polymerase Chain Reaction Market
8.3.5. Italy Polymerase Chain Reaction Market
8.3.6. Rest of Europe Polymerase Chain Reaction Market
8.4. Asia-Pacific Polymerase Chain Reaction Market Snapshot
8.4.1. China Polymerase Chain Reaction Market
8.4.2. India Polymerase Chain Reaction Market
8.4.3. Japan Polymerase Chain Reaction Market
8.4.4. Australia Polymerase Chain Reaction Market
8.4.5. South Korea Polymerase Chain Reaction Market
8.4.6. Rest of Asia Pacific Polymerase Chain Reaction Market
8.5. Latin America Polymerase Chain Reaction Market Snapshot
8.5.1. Brazil Polymerase Chain Reaction Market
8.5.2. Mexico Polymerase Chain Reaction Market
8.6. Rest of The World Polymerase Chain Reaction Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abbott
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Qiagen
9.2.3. Bio-Rad Laboratories, Inc.
9.2.4. Agilent Technologies, Inc.
9.2.5. Thermo Fisher Scientific, Inc.
9.2.6. Cytiva (GE Healthcare)
9.2.7. bioMérieux SA
9.2.8. Hoffmann-La Roche Ltd.
9.2.9. Fluidigm Corporation
9.2.10. Stilla
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
no record found